Finance

Lists
Why is ALK-B down 2.37%?
Dive Deeper
ALK-B:CPH
ALK-Abello A/S
DKK 239.20
-2.37%
(-5.80) 1D
Nov 20, 5:00:00 PM GMT+1  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for ALK-B...
Open
DKK 243.80
High
DKK 244.00
Low
DKK 238.60
Mkt. cap
48.45B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKK 271.40
52-wk low
DKK 191.80
Shares outstanding
202.57M
No. of employees
3K
Open
DKK 243.80
High
DKK 244.00
Low
DKK 238.60
Mkt. cap
48.45B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKK 271.40
52-wk low
DKK 191.80
Shares outstanding
202.57M
No. of employees
3K
News stories
From web sources and news partners
Profile
ALK-AbellĂł A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.8K
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.73B
1.77B
1.80B
1.76B
Cost of goods sold
543.00M
543.00M
600.00M
568.00M
Cost of revenue
543.00M
543.00M
600.00M
-
Research and development expenses
189.00M
151.00M
168.00M
197.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
605.00M
507.00M
582.00M
530.00M
Operating expense
793.00M
658.00M
750.00M
727.00M
Total operating expenses
1.34B
1.20B
1.35B
1.30B
Operating income
397.00M
570.00M
445.00M
-
Other non operating income
-
-
-
-
EBT including unusual items
393.00M
583.00M
452.00M
482.00M
EBT excluding unusual items
403.00M
583.00M
452.00M
482.00M
Income tax expense
127.00M
146.00M
113.00M
120.00M
Effective tax rate
32.32%
25.04%
25.00%
-
Other operating expenses
-1.00M
-
-
-
Net income
266.00M
437.00M
339.00M
-
Net profit margin
15.35%
24.68%
18.89%
20.52%
Earnings per share
1.20
2.00
1.50
1.60
Interest and investment income
28.00M
13.00M
7.00M
13.00M
Interest expense
-6.00M
-
-
-
Net interest expenses
22.00M
13.00M
7.00M
13.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
400.00M
654.00M
531.00M
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps